Molecular Stethoscope
company
About
Molecular Stethoscope, Inc., a San Diego, CA-based biotechnology company developing novel blood-based early detection.
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $8.19M
- Industries
- Biotechnology,Health Care,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this powerful non-invasive approach, Molecular Stethoscope aims to transform healthcare by providing early insight into a patient’s healthy versus disease state.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$8.19M
Molecular Stethoscope has raised a total of
$8.19M
in funding over 2 rounds. Their latest funding was raised on
Jun 7, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 7, 2022 | Grant | — | 1 |
|
— | Detail |
| Jan 5, 2017 | Seed | $8.19M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Molecular Stethoscope is funded by 2 investors.
ADDF's Diagnostics Accelerator
and Pfizer
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Grant |
Pfizer
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
